MaaT Pharma Publishes its 2021 Annual Results and Provides a Business Overview
As of December 31, 2021, cash and cash equivalents were €43.3 million and turnover was €1.0 million Success of Euronext Paris IPO in November 2021 with €35.7 million capital raised, after
Source: finanznachrichten.de